Evid Invest
Who owns KLRAWhat KLRA owns — n/a

Who owns Kailera Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of KLRA from SEC Form 13F filings across 132 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 132 institutions disclosed 119.7M shares of Kailera Therapeutics, Inc. worth $1.37B — about 92.3% of shares outstanding; the largest disclosed holder is Bain Capital Investors LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

132

13F holders

$1.37B

value, 2026 filers

92.3%

of shares outstanding (119.7M sh)

49

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of KLRA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Bain Capital Investors LLC26.3M$299.8M6.3%20.3%0.0%
2Bain Capital Life Sciences Investors, LLC22.6M$257.9M17.3%17.4%0.0%
3RTW INVESTMENTS, LP10.8M$123.1M1.2%8.3%0.0%
4CANADA PENSION PLAN INVESTMENT BOARD7.3M$83.4M0.0%5.6%0.0%
5Atlas Venture Life Science Advisors, LLC5.2M$59.1M9.4%4%0.0%
6FMR LLC4.7M$53.2M0.0%3.6%+17.4%
7BlackRock, Inc.4.6M$52.2M0.0%3.5%+16.4%
8ADAGE CAPITAL PARTNERS GP, L.L.C.4.2M$47.7M0.1%3.2%+30.1%
9CITADEL ADVISORS LLC3.6M$41.7M0.0%2.8%+12.6%
10Royalty Pharma Sub-Manager, LLC2.5M$28.0M14.3%1.9%0.0%
11STATE STREET CORP2.2M$25.6M0.0%1.7%+158.2%
12Siren, L.L.C.2.2M$25.3M0.6%1.7%0.0%
13AMERIPRISE FINANCIAL INC2.1M$23.9M0.0%1.6%+155.0%
14VANGUARD CAPITAL MANAGEMENT LLC1.7M$19.2M0.0%1.3%-0.7%
15VANGUARD PORTFOLIO MANAGEMENT LLC1.6M$18.5M0.0%1.2%-2.0%
16GEODE CAPITAL MANAGEMENT, LLC1.2M$13.8M0.0%0.9%+6.5%
17Frazier Life Sciences Management, L.P.1.2M$13.7M0.3%0.9%+9.1%
18FARALLON CAPITAL MANAGEMENT, L.L.C.1.1M$12.6M0.1%0.8%0.0%
19Trails Edge Capital Partners, LP942,953$10.8M1.5%0.7%-4.2%
20MARSHALL WACE, LLPNEW878,196$10.0M0.0%0.7%new
21MILLENNIUM MANAGEMENT LLCNEW858,972$9.8M0.0%0.7%new
22GOLDMAN SACHS GROUP INC696,577$8.0M0.0%0.5%+65.4%
23PRICE T ROWE ASSOCIATES INC /MD/631,951$7.2M0.0%0.5%-82.1%
24Vestal Point Capital, LP625,000$7.1M0.2%0.5%+8.7%
25UBS Group AG469,584$5.4M0.0%0.4%-51.7%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.